Target intelligence / Profile preview

Leucine-rich repeat and calponin homology domain-containing protein 4 (LRCH4)

Target
LRCH4
Molecular classification
Accessory protein, Membrane-bound protein, Pattern recognition receptor–like protein, Other (not a classical receptor, enzyme, ion channel, or transporter, though functionally closely linked with immune receptors)
01

Overview

Leucine-rich repeat and calponin homology domain-containing protein 4 (**LRCH4**) is a membrane-associated protein characterized by an N-terminal leucine-rich repeat (LRR) ectodomain that forms a horseshoe-like structure involved in ligand capture, a central intrinsically disordered region, and a C-terminal calponin homology (CH) domain, often accompanied by a transmembrane segment. LRCH4 plays a regulatory role in innate immune signaling and is necessary for optimal activation of Toll-like receptor 4 (TLR4) in response to bacterial lipopolysaccharide (LPS). It contributes to downstream induction of both MyD88-dependent and TRIF-dependent cytokines, as well as activation of transcription factors such as NF-κB and IRF3 after LPS exposure. LRCH4 is hypothesized to mediate organization and activity within lipid raft microdomains, possibly facilitating efficient TLR4 clustering and signaling. Additionally, LRCH4 interacts with cytoskeletal partner proteins (such as Coro1A) and may impact cell division, proliferation, and actin dynamics as part of broader cellular functions. While not itself a conventional receptor, LRCH4 acts as an accessory or scaffold protein in innate immune receptor complexes. It is widely expressed, evolutionarily conserved, and currently under study as a potential molecular target in inflammatory and infectious diseases.

Other names
LRRN4LRRN1LRNPP14183Leucine-rich repeat neuronal protein 4Leucine-rich neuronal proteinleucine-rich repeat and calponin homology (CH) domain containing 4
02

Mechanism of action

Not applicable; no direct drugs currently interact with LRCH4. Mechanistically, future drugs might aim to modulate innate immune signaling or TLR4 pathway if targeting LRCH4.

03

Biological functions

Regulation of innate immune signaling (modulates Toll-like receptor signaling, especially TLR4)Promotion and fine-tuning of cytokine production in response to bacterial components (LPS)Cell division and proliferation (some evidence of regulation, mainly from family studies)Regulation of actin cytoskeleton network through protein interactionsLipid raft organization and signal transduction
04

Disease associations

Inflammation (potential role in inflammatory diseases due to regulation of TLR signaling)Infection (modulates response to microbial challenge via TLR4 pathway)Neurodegenerative disease (family members, including LRCH4, show altered expression in aging brains)Other (possible broader role in immune disorders due to impact on cytokine induction and signaling pathways)
05

Safety considerations

No direct safety or toxicity concerns described for targeting LRCH4. Therapeutic interventions modulating LRCH4 would need caution due to its pivotal role in innate immune responses—there may be risk of immunosuppression or exaggerated inflammation if pathway balance is disrupted
06

Interacting drugs

No direct drugs reported to target LRCH4 in the current literature. LRCH4 is functionally involved in pathways modulated by anti-inflammatory drugs and drugs targeting TLRs, but is not itself a direct pharmacological target yet
07

Biomarkers

No validated biomarkers currently in clinical use for LRCH4. Future utility could be in monitoring immune activation or responses to LPS/TLR agonists

Beyond the preview

Go deeper on Leucine-rich repeat and calponin homology domain-containing protein 4 (LRCH4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leucine-rich repeat and calponin homology domain-containing protein 4 (LRCH4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call